DoJ Launching “Pharmaceutical Fraud Initiative” Ahead Of Medicare Rx Implementation
This article was originally published in The Pink Sheet Daily
Executive Summary
The initiative will coordinate and increase civil and criminal enforcement resources. DoJ is also working with CMS to prevent fraud by aiding in the design and implementation of the Medicare drug benefit.
You may also be interested in...
State Health Fraud Task Forces To Receive FDA Grants
The agency will provide $300,000 in fiscal 2004 for 20 grants to states to investigate and disseminate information on the use of fraudulent drugs.
State Health Fraud Task Forces To Receive FDA Grants
The agency will provide $300,000 in fiscal 2004 for 20 grants to states to investigate and disseminate information on the use of fraudulent drugs.
States Searching For Ways To Prosecute Medicare Discount Card Fraud
Despite a “preemption clause” generally preventing states from intervening in the Medicare drug benefit program, states are “looking over everyone’s shoulder” at discount cards, Pharmaceutical Care Management Association attorney says.